Search Results - V. I. Petrov

Refine Results
  1. 1
    Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025

    Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025 by V. I. Petrov

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events”

    Review of the textbook “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events” by V. I. Petrov

    Published 2024-04-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    THE TECHNIQUE OF ANALYSIS OF SOFTWARE OF ON-BOARD COMPUTERS OF AIR VESSEL TO ABSENCE OF UNDECLARED CAPABILITIES BY SIGNATURE-HEURISTIC WAY

    THE TECHNIQUE OF ANALYSIS OF SOFTWARE OF ON-BOARD COMPUTERS OF AIR VESSEL TO ABSENCE OF UNDECLARED CAPABILITIES BY SIGNATURE-HEURISTIC WAY by V. I. Petrov

    Published 2017-03-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Quantitative clinical pharmacology and patient-centered healthcare technologies: perspectives 2030

    Quantitative clinical pharmacology and patient-centered healthcare technologies: perspectives 2030 by V. I. Petrov, B. E. Tolkachev

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Safety of Using Contrast Agents in Coronary Angiography in a Multidisciplinary Hospital in Volgograd

    Safety of Using Contrast Agents in Coronary Angiography in a Multidisciplinary Hospital in Volgograd by V. I. Petrov, A. A. Kudasheva

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)

    ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) by V. I. Petrov, O. V. Shatalova, A. S. Maslakov

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study

    The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19

    Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19 by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Risk of secondary bacterial infections during treatment with anti-inflammatory genetically engineered biological drugs in COVID-19 patients

    Risk of secondary bacterial infections during treatment with anti-inflammatory genetically engineered biological drugs in COVID-19 patients by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2025-03-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE

    INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE by V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020

    Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 by A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov

    Published 2022-01-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease

    Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease by V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko

    Published 2019-09-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation

    Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation by V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage

    Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage by A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE

    PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE by V. I. Petrov, A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova

    Published 2021-01-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Experience of Using Remdesivir in Patients with Novel Coronavirus Infection

    Experience of Using Remdesivir in Patients with Novel Coronavirus Infection by V. I. Petrov, A. Yu. Ryazanova, N. S. Privaltseva, D. A. Nekrasov

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)

    POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19) by V. I. Petrov, A. Yu. Ryazanova, N. S. Privaltseva, D. A. Nekrasov

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation

    Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation by V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta

    Published 2021-09-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS

    MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS by V. I. Petrov, O. V. Shatalova, A. S. Maslakov, A. V. Kushkinova

    Published 2014-08-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN

    ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN by V. I. Petrov, I. N. Shishimorov, O. V. Magnitskaya, Ju. V. Ponomareva

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: